Published in Emerg Infect Dis on November 09, 2000
Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol (2002) 6.60
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J Virol (2000) 1.79
Replicon system for Lassa virus. J Virol (2004) 1.69
Nosocomial outbreak of novel arenavirus infection, southern Africa. Emerg Infect Dis (2009) 1.50
Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J Virol (2009) 1.45
Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA. J Clin Microbiol (2010) 1.45
Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus. BMC Infect Dis (2004) 1.45
Detection of Lassa virus, Mali. Emerg Infect Dis (2010) 1.41
Novel arenavirus sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Côte d'Ivoire: implications for evolution of arenaviruses in Africa. PLoS One (2011) 1.32
Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol (2004) 1.30
Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J (2011) 1.29
Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis (2012) 1.27
Pathogenesis of Lassa fever. Viruses (2012) 1.23
An N-terminal region of Lassa virus L protein plays a critical role in transcription but not replication of the virus genome. J Virol (2009) 1.22
Current molecular epidemiology of Lassa virus in Nigeria. J Clin Microbiol (2010) 1.15
Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Virol J (2011) 1.13
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. Vaccine (2007) 1.13
Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol J (2011) 1.13
Mopeia virus-related arenavirus in natal multimammate mice, Morogoro, Tanzania. Emerg Infect Dis (2009) 1.11
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology (2006) 1.06
Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages. J Virol (2011) 1.06
Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali. PLoS Negl Trop Dis (2013) 1.06
Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus. J Virol (2011) 1.02
Structure of the Lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy. J Biol Chem (2011) 1.01
The first cases of Lassa fever in Ghana. Ghana Med J (2012) 0.98
The role of single N-glycans in proteolytic processing and cell surface transport of the Lassa virus glycoprotein GP-C. Virol J (2006) 0.96
Preparing a community hospital to manage work-related exposures to infectious agents in BioSafety level 3 and 4 laboratories. Emerg Infect Dis (2010) 0.95
A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques. J Infect Dis (2013) 0.94
Broad-spectrum antiviral activity of small interfering RNA targeting the conserved RNA termini of Lassa virus. Antimicrob Agents Chemother (2007) 0.92
Multifunctional nature of the arenavirus RING finger protein Z. Viruses (2012) 0.92
Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever. Clin Vaccine Immunol (2007) 0.91
Advanced vaccine candidates for Lassa fever. Viruses (2012) 0.90
Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers. PLoS One (2013) 0.90
Two novel arenaviruses detected in pygmy mice, Ghana. Emerg Infect Dis (2013) 0.88
Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study. PLoS Negl Trop Dis (2009) 0.87
International external quality assessment study for molecular detection of Lassa virus. PLoS Negl Trop Dis (2015) 0.87
Immune responses and Lassa virus infection. Viruses (2012) 0.86
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. Sci Rep (2015) 0.85
The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines (2013) 0.84
Retrospective evaluation of control measures for contacts of patient with Marburg hemorrhagic fever. Emerg Infect Dis (2012) 0.84
Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers. Viruses (2012) 0.84
Lassa Virus in Multimammate Rats, Côte d'Ivoire, 2013. Emerg Infect Dis (2015) 0.83
Sequence variability and geographic distribution of Lassa virus, Sierra Leone. Emerg Infect Dis (2015) 0.83
Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front Microbiol (2015) 0.81
Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever. PLoS Negl Trop Dis (2014) 0.81
Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali. Emerg Infect Dis (2016) 0.81
Guidance for contact tracing of cases of Lassa fever, Ebola or Marburg haemorrhagic fever on an airplane: results of a European expert consultation. BMC Public Health (2012) 0.79
Constraints in the diagnosis and treatment of Lassa Fever and the effect on mortality in hospitalized children and women with obstetric conditions in a rural district hospital in Sierra Leone. Trans R Soc Trop Med Hyg (2014) 0.78
Rapid detection of Lassa virus by reverse transcription-loop-mediated isothermal amplification. Microbiol Immunol (2011) 0.78
Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa. Pharmacogenomics J (2016) 0.78
Lassa Fever in Pregnancy: Report of 2 Cases Seen at the University College Hospital, Ibadan. Case Rep Obstet Gynecol (2016) 0.76
In silico prediction of B- and T- cell epitope on Lassa virus proteins for peptide based subunit vaccine design. Adv Biomed Res (2015) 0.76
Annual Incidence of Lassa Virus Infection in Southern Mali. Am J Trop Med Hyg (2017) 0.75
Imported Lassa fever: a report of 2 cases in Ghana. BMC Infect Dis (2015) 0.75
Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell (1986) 42.45
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg (1970) 4.96
Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am J Trop Med Hyg (1970) 4.29
A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 3.71
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44
Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg (1974) 2.95
Early diagnosis of Lassa fever by reverse transcription-PCR. J Clin Microbiol (1994) 2.65
Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med (1990) 2.57
Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36
Site-specific antibodies define a cleavage site conserved among arenavirus GP-C glycoproteins. J Virol (1987) 1.87
Fine mapping of a peptide sequence containing an antigenic site conserved among arenaviruses. Virology (1988) 1.70
Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. Virology (1997) 1.44
Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products. Virus Res (1991) 1.37
Sequence analysis of the S RNA of the African arenavirus Mopeia: an unusual secondary structure feature in the intergenic region. Virology (1991) 1.35
Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J Gen Virol (1991) 1.35
Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol (1998) 1.34
Generation of reassortants between African arenaviruses. Virology (1992) 1.33
Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Lancet (1987) 1.28
Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology (1989) 1.25
Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. Virology (1989) 1.25
Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci U S A (1989) 1.25
Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J Virol (2000) 1.24
Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J Clin Microbiol (1998) 1.24
Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. Trans R Soc Trop Med Hyg (1985) 1.23
Lassa fever: response to an imported case. N Engl J Med (1977) 1.23
An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis (1988) 1.21
Imported Lassa fever--reexamining the algorithms. N Engl J Med (1990) 1.18
Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. Trans R Soc Trop Med Hyg (1985) 1.17
Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Arch Virol (1989) 1.12
A single nucleotide change in the 5' noncoding region of Sindbis virus confers neurovirulence in rats. J Virol (1999) 1.11
Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus. J Virol (1993) 1.06
Lassa fever: the first confirmed case imported into Canada. Can Dis Wkly Rep (1989) 1.05
Deleted viral RNAs and lymphocytic choriomeningitis virus persistence in vitro. J Gen Virol (1988) 0.91
Lassa fever: implications of T-cell immunity for vaccine development. J Biotechnol (1999) 0.89
Identification of Lassa fever virus infection with recombinant nucleocapsid protein antigen. Lancet (1989) 0.83
Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1. Arch Virol (1990) 0.81
[The localization and preliminary characteristics of antigenic sites (B epitopes) in the nucleocapsid protein of the Lassa virus]. Vopr Virusol (1994) 0.81
Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc Natl Acad Sci U S A (2001) 7.99
Exons encode functional and structural units of chicken lysozyme. Proc Natl Acad Sci U S A (1980) 4.01
Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78
beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol (1999) 3.47
Worldwide epidemiology of human adenovirus infections. Am J Epidemiol (1983) 3.45
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A (2001) 3.43
Role of chromosome territories in the functional compartmentalization of the cell nucleus. Cold Spring Harb Symp Quant Biol (1993) 3.38
Detection of dengue virus RNA in patients after primary or secondary dengue infection by using the TaqMan automated amplification system. J Clin Microbiol (1999) 2.96
Central nervous system lesions and cervical disc herniations in amateur divers. Lancet (1995) 2.84
KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch (2008) 2.78
Autochthonous dengue virus infection in Japan imported into Germany, September 2013. Euro Surveill (2014) 2.73
Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract (1998) 2.63
IgM antibodies to Epstein-Barr virus in infectious mononucleosis. Arch Gesamte Virusforsch (1972) 2.47
Multiple mRNAs are generated from the chicken lysozyme gene. Cell (1981) 2.46
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
Detection of IgM antibodies to cytomegalovirus (CMV) using an enzyme-labelled antigen (ELA). J Gen Virol (1980) 2.13
Determination of different cytomegalovirus immunoglobulins (IgG, IgA, IgM) by immunofluorescence. Arch Gesamte Virusforsch (1972) 2.04
First case of laboratory-confirmed Zika virus infection imported into Europe, November 2013. Euro Surveill (2014) 2.02
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Tomographic 3D reconstruction of quick-frozen, Ca2+-activated contracting insect flight muscle. Cell (1999) 1.85
Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulated by beta-catenin. Cancer Res (2001) 1.83
Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol (1992) 1.80
Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein. J Virol (2000) 1.79
The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calcif Tissue Res (1973) 1.77
Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus. J Clin Microbiol (1977) 1.75
Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea. Am J Trop Med Hyg (1996) 1.70
Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol (2000) 1.66
The crystal structure of nucleoplasmin-core: implications for histone binding and nucleosome assembly. Mol Cell (2001) 1.66
Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction. J Clin Microbiol (1990) 1.61
Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci (2000) 1.60
Development of a standard set of microsatellite reference alleles for identification of grape cultivars. Theor Appl Genet (2004) 1.52
Fatal dengue hemorrhagic fever imported into Germany. Infection (2011) 1.51
The prevalence of antibodies to HIV-1 and HIV-2 in onchocerciasis-endemic rural areas in southern Benin. AIDS (1993) 1.44
Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis (2001) 1.40
Innate immunity in cystic fibrosis lung disease. J Cyst Fibros (2012) 1.38
IgM antibodies to cytomegalovirus during pregnancy. Arch Virol (1977) 1.38
Hantavirus pulmonary syndrome in Germany. Lancet (1996) 1.38
X-ray diffraction indicates that active cross-bridges bind to actin target zones in insect flight muscle. Biophys J (1998) 1.38
Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc Natl Acad Sci U S A (1997) 1.35
Microbial and chemical transformations of some 12,13-epoxytrichothec-9,10-enes. Appl Environ Microbiol (1978) 1.32
Arthroscopic treatment of septic joints: prognostic factors. Arch Orthop Trauma Surg (2002) 1.32
Cimetidine for anastomotic ulcers after partial gastrectomy. A randomized controlled trial. N Engl J Med (1979) 1.32
Improved detection of virus-specific IgM antibodies. Elimination of non-specific IgM binding. J Gen Virol (1978) 1.31
Clinical evaluation of patients with infectious mononucleosis and development of antibodies to the R component of the Epstein-Barr virus-induced early antigen complex. Am J Med (1975) 1.30
Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum (2000) 1.27
Mechanisms of sulfadoxine resistance in Plasmodium falciparum. Mol Biochem Parasitol (1986) 1.27
Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation (1982) 1.27
Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme. J Virol (2001) 1.25
Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J Gen Virol (1992) 1.25
Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J Virol (2000) 1.24
Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use. J Clin Microbiol (1998) 1.24
Negative regulation of CD4 expression in T cells by the transcriptional repressor ZEB. Int Immunol (1999) 1.24
Antibodies to human cytomegalovirus structural polypeptides during primary infection. J Virol Methods (1988) 1.23
Genetic identification of Kodoko virus, a novel arenavirus of the African pigmy mouse (Mus Nannomys minutoides) in West Africa. Virology (2007) 1.22
Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Trop Med Int Health (1999) 1.22
Effect of smoking on duodenal ulcer healing with cimetidine and oxmetidine. Gut (1982) 1.22
Stage-dependent inhibition of chloroquine on Plasmodium falciparum in vitro. J Parasitol (1986) 1.21
Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol (2002) 1.21
Predictive value of nuclear beta-catenin expression for the occurrence of distant metastases in rectal cancer. Dis Colon Rectum (1998) 1.20
Seroepidemiology of human immunodeficiency virus in Africa. Br Med J (Clin Res Ed) (1986) 1.20
A haemorrhagic fever from the Côte d'Ivoire. Lancet (1999) 1.17
Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol (2001) 1.17
Diagnosis of human cytomegalovirus-induced retinitis in human immunodeficiency virus type 1-infected subjects by using the polymerase chain reaction. J Clin Microbiol (1991) 1.16
CD34+ hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood (1990) 1.15
Duodenal biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion. AIDS (1998) 1.14
Detection of immunoglobulin M antibody to Epstein-Barr virus by use of an enzyme-labeled antigen. J Clin Microbiol (1982) 1.13
Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies. Arch Virol (1989) 1.12
Mechanisms of diarrhea in the interleukin-2-deficient mouse model of colonic inflammation. Am J Physiol Gastrointest Liver Physiol (2004) 1.12
Imported tropical virus infections in Germany. Arch Virol Suppl (1996) 1.11
Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. J Immunol (1994) 1.09
Quality assurance for the diagnostics of viral diseases to enhance the emergency preparedness in Europe. Euro Surveill (2005) 1.08
Acute Epstein-Barr virus infections in children. Med Microbiol Immunol (1972) 1.08
Antitumor activity of 15-acetoxyscirpen-3,4-diol. J Antibiot (Tokyo) (1978) 1.08
Fate of intravenously injected pyrophosphate-32P in dogs. Am J Physiol (1970) 1.07
Detection of Usutu virus infection in a healthy blood donor from south-west Germany, 2012. Euro Surveill (2012) 1.07
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104. Br J Cancer (2012) 1.07
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial. J Cancer Res Clin Oncol (2014) 1.07
ANT1, an aromatic and neutral amino acid transporter in Arabidopsis. Plant Physiol (2001) 1.06
Plasmodium vinckei: suppression of mouse infections with desferrioxamine B. Exp Parasitol (1985) 1.05
Efficacy of surgical measures in preventing port-site recurrences in a porcine model. Surg Endosc (2001) 1.04
Rift Valley fever in Nigeria: infections in domestic animals. Rev Sci Tech (1996) 1.04
Simple detection of fluorescent stained IgM in sucrose gradients: demonstration of virus-specific IgM. Intervirology (1974) 1.04
The infrared receptor of Melanophila acuminata De Geer (Coleoptera: Buprestidae): ultrastructural study of a unique insect thermoreceptor and its possible descent from a hair mechanoreceptor. Tissue Cell (1995) 1.03
Inorganic pyrophosphate pool size and turnover rate in arthritic joints. J Clin Invest (1975) 1.03
International diagnostic accuracy study for the serological detection of chikungunya virus infection. Clin Microbiol Infect (2009) 1.02
A novel model for the study of the therapy of flavivirus infections using the Modoc virus. Virology (2001) 1.02
Toscana virus causing severe meningoencephalitis in an elderly traveller. J Neurol Neurosurg Psychiatry (2005) 1.02
Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells. Biol Chem (2000) 1.02
Detection of HIV-1 DNA in different subsets of human peripheral blood mononuclear cells using the polymerase chain reaction. Rapid communication. Arch Virol (1989) 1.01
An improved technique for the diagnosis of viral retinitis from samples of aqueous humor and vitreous. Graefes Arch Clin Exp Ophthalmol (1993) 1.00
Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate. Bone (1988) 1.00